The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models
Top Cited Papers
Open Access
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 7 (1) , 29-37
- https://doi.org/10.1186/ar1478
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17Journal of Biological Chemistry, 2003
- Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritisClinical and Experimental Immunology, 2002
- PATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVOCytokine, 2001
- The combination of tumor necrosis factor ? blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo modelArthritis & Rheumatism, 2001
- IL‐17‐induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen‐activated protein (MAP) kinasesBritish Journal of Pharmacology, 2001
- Expression of IL-17 mRNA in Ovarian CancerBiochemical and Biophysical Research Communications, 2001
- Interleukin-17: A New Bone Acting Cytokine In VitroJournal of Bone and Mineral Research, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Interleukin-17-induced Gene Expression in Articular Chondrocytes Is Associated with Activation of Mitogen-activated Protein Kinases and NF-κBJournal of Biological Chemistry, 1998